A meta-analysis of the effect of glucagon-like peptide-1 (7-36) amide on ad libitum energy intake in humans.
By C. Verdich, A. Flint, J. Gutzwiller, E. Näslund, C. Beglinger, P. Hellström, S. J. Long, L. Morgan, J. Holst, A. Astrup. Journal of Clinical Endocrinology and Metabolism, 2001
679 citations recorded by the source corpus.
Subfields: Endocrine and Autonomic Systems, Physiology
View Paper: https://www.semanticscholar.org/paper/07afc8633c087ff90076e09870bb6b6e2090d85c
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Endocrine and Autonomic Systems
In Physiology
Citations in the corpus
- The Role of Incretins in Glucose Homeostasis and Diabetes Treatment (2008, background): “These effects of GLP-1 are observed in lean and obese as well as diabetic humans (Flint et al., 1998; Näslund et al., 1999; Verdich et al., 2001; Zander et al., 2002).”
- Enhancing incretin action for the treatment of type 2 diabetes. (2003, background): “A metaanalysis of available data from 115 subjects demonstrated significant GLP-1– dependent reductions in energy consumption in lean and overweight subjects (137).”
- Casein and whey exert different effects on plasma amino acid profiles, gastrointestinal hormone secretion and appetite (2003, background): “Both hormones have previously both been shown to play an important role in satiety in human subjects (Ballinger & Clark, 1994; Lieverse et al. 1994; Gutzwiller et al. 1999; Verdich et al. 2001).”
- Neuroendocrine control of food intake. (2008, neutral): “a recent meta-analysis of seven studies, a significant dose-dependent decrease in ad libitum caloric intake was shown both in lean and obese subjects [17].”